The Singapore Association of Pharmaceutical Industries' (SAPI) recently appointed president, Ti Hwei How highlights several unique attributes that distinguish Singapore’s renowned healthcare system from others around the world, while delineating three potential avenues for expanding patient access to innovative medicines.
To begin, Ti Hwei, how would you characterize the specificities of the country’s healthcare system?
We spend 5.1% of our GDP on health care, while the OECD countries spend an average of 9.3%.
